Abstract
ObjectivesMethotrexate (MTX) is the mainstay treatment for juvenile idiopathic arthritis (JIA), however approximately 30% of children will fail to respond to the drug. Identification of genetic predictors of response to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have